ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2866

Lupus HDL Induces Pro-Inflammatory Responses in Macrophages By Binding LOX1Rand Failing to Promote ATF3 Activity

Carolyne K. Smith1, Nickie Seto1, Anuradha Vivekanandan-Giri2, Wenmin Yuan3, Martin Playford4, Zerai G. Manna5, Sarfaraz A. Hasni6, Rui Kuai3, Nehal N. Mehta4, Anna Schwendeman3, Subramaniam Pennathur2 and Mariana Kaplan7, 1Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2Internal Medicine/Nephrology, University of Michigan Nephrology, Ann Arbor, MI, 3Department of Medicinal Chemistry and the Biointerfaces Institute, University of Michigan, Ann Arbor, MI, 4NHLBI, National Institutes of Health, Bethesda, MD, 5National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 6Lupus Clinical Research Program, Office of the Clinical Director, NIAMS/NIH, Bethesda, MD, 7NIAMS/NIH, Bethesda, MD

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Cardiovascular disease, inflammation and macrophages, Lupus

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Recent evidence indicates that high-density lipoprotein (HDL) exerts vasculoprotective activities by promoting activating transcription factor 3 (ATF3), leading to down-regulation of TLR-induced inflammatory responses. Systemic lupus erythematosus (SLE) is associated with increased cardiovascular disease (CVD) risk not explained by the Framingham risk score. Recent studies have indicated oxidized HDL as a possible contributor. We investigated the potential mechanisms by which lupus HDL may lose its anti-inflammatory effects and promote immune dysregulation.

Methods: Control human macrophages were challenged with purified human control and SLE HDL in vitro in the presence or absence of TLR agonists and examined for induction of inflammatory markers by real time RT-PCR, confocal microscopy, ELISA and flow cytometry. The effect of an HDL mimetic (ETC-642) was examined in vivo in NZM2328 lupus-prone mice.

Results: Compared to control HDL, SLE HDL activates NFκB, promotes inflammatory cytokine production, and fails to block TLR-induced inflammation in control macrophages. This failure of lupus HDL to block inflammatory responses is due to an impaired ability to promote ATF3 synthesis and nuclear translocation. SLE HDL-induced pro-inflammatory responses in macrophages are dependent on its binding to lectin-like oxidized low-density lipoprotein receptor 1 (LOX1R), which promotes suppression of ATF3 activity in a ROCK1/2 kinase-dependent manner. This inflammation can be modulated in vivo as lupus-prone mice exposed to ETC-642 show improved ATF3 induction and significant abrogation of pro-inflammatory responses.

Conclusion: Lupus HDL promotes pro-inflammatory responses through activation of NFκB and decreased ATF3 synthesis and activity, in a LOX1R- and ROCK1/2 kinase-dependent manner. HDL mimetics should be further explored as potential therapies to hamper inflammation and reduce cardiovascular risk in SLE.


Disclosure: C. K. Smith, None; N. Seto, None; A. Vivekanandan-Giri, None; W. Yuan, None; M. Playford, None; Z. G. Manna, None; S. A. Hasni, None; R. Kuai, None; N. N. Mehta, None; A. Schwendeman, None; S. Pennathur, None; M. Kaplan, None.

To cite this abstract in AMA style:

Smith CK, Seto N, Vivekanandan-Giri A, Yuan W, Playford M, Manna ZG, Hasni SA, Kuai R, Mehta NN, Schwendeman A, Pennathur S, Kaplan M. Lupus HDL Induces Pro-Inflammatory Responses in Macrophages By Binding LOX1Rand Failing to Promote ATF3 Activity [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/lupus-hdl-induces-pro-inflammatory-responses-in-macrophages-by-binding-lox1rand-failing-to-promote-atf3-activity/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lupus-hdl-induces-pro-inflammatory-responses-in-macrophages-by-binding-lox1rand-failing-to-promote-atf3-activity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology